# Cystadrops in Pediatric Cystinosis Patients From Six Months to Less Than Two Years Old (SCOB2)

> **NCT04125927** · PHASE3 · COMPLETED · sponsor: **RECORDATI GROUP** · enrollment: 5 (actual)

## Conditions studied

- Cystinosis

## Interventions

- **DRUG:** Mercaptamine

## Key facts

- **NCT ID:** NCT04125927
- **Lead sponsor:** RECORDATI GROUP
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-01
- **Primary completion:** 2022-12-23
- **Final completion:** 2022-12-23
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2024-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04125927

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04125927, "Cystadrops in Pediatric Cystinosis Patients From Six Months to Less Than Two Years Old (SCOB2)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04125927. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*